A carregar...
Integration of Multiple “Omic” Biomarkers: A Precision Medicine Strategy for Lung Cancer
More than half of all new lung cancer diagnoses are made in patients with locally advanced or metastatic disease, at which point therapeutic options are scarce. It is anticipated, however, that the widespread use of Low-Dose Computed Tomography (LDCT) screening, will lead to a greater proportion of...
Na minha lista:
| Publicado no: | Lung Cancer |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5156586/ https://ncbi.nlm.nih.gov/pubmed/27344275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2016.06.003 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|